In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to Cellectar Biosciences (CLRB – Research
Tag: Jason McCarthy
Maxim Group Assigns a Buy Rating on GeoVax Labs (GOVX)
Maxim Group analyst Jason McCarthy assigned a Buy rating to GeoVax Labs (GOVX – Research Report) yesterday and set a
Maxim Group Assigns a Buy Rating on Cyclo Therapeutics (CYTH)
In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to Cyclo Therapeutics (CYTH – Research
AzurRx BioPharma (AZRX) Receives a New Rating from a Top Analyst
In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to AzurRx BioPharma (AZRX – Research
Actinium Pharmaceuticals (ATNM) Received its Third Buy in a Row
After H.C. Wainwright and William Blair gave Actinium Pharmaceuticals (NYSE MKT: ATNM) a Buy rating last month, the company received
Actinium Pharmaceuticals (ATNM) Received its Third Buy in a Row
After H.C. Wainwright and William Blair gave Actinium Pharmaceuticals (NYSE MKT: ATNM) a Buy rating last month, the company received
Maxim Group Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)
Maxim Group analyst Jason McCarthy reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report) yesterday and set a